AI-bio’s credit wars: cofounders, IP ownership, and model risk
What Changed and Why It Matters Founders are hitting an IP wall. As AI moves into biotech and R&D-heavy startups, teams are learning the hard way that AI outputs often…
What Changed and Why It Matters Founders are hitting an IP wall. As AI moves into biotech and R&D-heavy startups, teams are learning the hard way that AI outputs often…